Search for: "Barr Pharmaceuticals Inc"
Results 101 - 120
of 162
Sort by Relevance
|
Sort by Date
8 Oct 2009, 3:04 pm
Barr Pharmaceuticals Inc., C.A. [read post]
8 Oct 2009, 6:05 am
Reddy’s, Barr and Purepac (Patent Baristas) Renagel (Sevelamer) – US: Genzyme files patent infringement suit against Endo Pharmaceuticals following Para IV challenge (Patent Docs) Roundup Ready cotton seed – US: Monsanto files patent infringement suits against Brent M Hargrove and Larry H Lytle based on defendants’ use of cotton seed produced from earlier planted Roundup Ready cotton seed (Patent Docs) Seroquel (Quetiapine) – US:… [read post]
27 Sep 2009, 2:30 pm
As we noted in Genentech, Inc. v. [read post]
26 Aug 2009, 5:14 pm
Barr Labs., Inc., No. 2008-1282, 2009 U.S. [read post]
26 Aug 2009, 9:20 am
Barr Labs., Inc., No. 2008-1282, 2009 U.S. [read post]
17 Aug 2009, 8:01 am
As a result, the giant generic pharmaceutical concern has become the utmost patent copycat pharmaceutical player on the international scene. [read post]
17 Aug 2009, 8:01 am
As a result, the giant generic pharmaceutical concern has become the utmost patent copycat pharmaceutical player on the international scene. [read post]
6 Aug 2009, 11:24 pm
Barr (CAFC 2008-1282) Barr provoked Bayer by filing to produce a generic version of the drug. [read post]
3 Aug 2009, 7:29 am
All responding defendants (Actavis, Inc.; Actavis-Elizabeth, L.L.C.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
6 Jul 2009, 4:54 pm
They are seeking to revive an antitrust lawsuti against brand-name drugmaker, Bayer AG, and its U.S. subsidiary, Bayer Corp., and a generic manufacturer, Barr Laboratories, Inc., along with Barr’s business partners who challenged Bayer, leading to the “reverse payments” deal. [read post]
18 Jun 2009, 5:19 pm
Brief amicus curiae of Academic Research Scientists Brief amicus curiae of Pharmaceutical Research and Manufacturers of America and Biotechnology Industry Organization Brief amicus curiae of Council of American Survey Research Organizations, Inc. and Pharmaceutical Marketing Research Group, Inc. [read post]
12 Jun 2009, 12:10 pm
Geneva Pharmaceuticals, Inc., 344 F.3d 1294 (11th Cir. 2003). [read post]
12 Jun 2009, 10:49 am
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition of respondents Barr Laboratories, Inc. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
5 May 2009, 5:57 am
Barr Pharmaceuticals, 07-395, U.S. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
16 Mar 2009, 8:52 pm
By Suresh Pillai -- Sepracor Settles Xopenex Suit With Barr Last week, Sepracor Inc. and Barr Pharmaceuticals, Inc. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
